(Q36470980)

14 August 2017

Susceptibility of Staphylococcus aureus to cefaclor and cephalothin: laboratory and clinical studies (English)

1 reference

14 August 2017

1 reference

Staphylococcus aureus

1 reference

Dillon HC Jr

3

1 reference

14 August 2017

B. M. Gray

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A677865

20 July 2022

C. A. Hubbell

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A677865

20 July 2022

H. C. Dillon

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A677865

20 July 2022

language of work or name

English

0 references

publication date

1 June 1978

1 reference

full work available at URL

14 August 2017

https://europepmc.org/articles/PMC352377

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A677865

https://europepmc.org/articles/PMC352377?pdf=render

20 July 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A677865

Antimicrobial Agents and Chemotherapy

20 July 2022

published in

1 reference

14 August 2017

13

1 reference

14 August 2017

6

1 reference

14 August 2017

988-991

1 reference

Stable antibiotic sensitivity disks

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352377

Comparison of in vitro antibacterial activity of three oral cephalosporins: cefaclor, cephalexin, and cephradine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352377

In vitro studies with cefaclor, a new oral cephalosporin

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352377

In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352377

Diffusion Disk Susceptibility Testing with Cefaclor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352377

In vitro susceptibility of selected bacteria to cefaclor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352377

Comparison of In Vitro Activity of Cephalexin, Cephradine, and Cefaclor

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352377

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352377

Impetigo contagiosa: suppurative and non-suppurative complications. I. Clinical, bacteriologic, and epidemiologic characteristics of impetigo.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=352377

28 June 2018

Identifiers

DOI

10.1128/AAC.13.6.988

1 reference

14 August 2017

1 reference

14 August 2017

1 reference